BYETTA

Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely, for use in slowing gastric emptying, improving glycemic control, increasing first-phase and second-phase insulin secretion, and in suppression of inappropriate glucagon secretion, and for the treatment and prevention of endocrine conditions and disorders, diabetes, diabetic complications, and hormonal diseases and disorders